Zaga MI, Mayorga VLD

Idioma: Español
Referencias bibliográficas: 16
Paginas: 33-37
Archivo PDF: 266.27 Kb.

FRAGMENTO

Los antiinflamatorios no esteroideos son drogas asociadas a eventos gastrointestinales significativos con consecuencias tanto económicas como clínicas. Las úlceras gástricas y duodenales son las más comúnmente estudiadas, sin embargo se ha visto recientemente que estos medicamentos pueden producir enteropatía en otras zonas del tubo digestivo (yeyuno e íleon).

REFERENCIAS (EN ESTE ARTÍCULO)

1. Caunedo A, Gomez BJ. Macroscopic small bowel mucosal injury caused by chronic nonsteroidal anti-inflammatory drugs (NSAI D) use as assessed by capsule endoscopy. Rev Esp Enferm Dig 2010; 102(2): 80-85.

2. Primary prevention of ulcers in patients taking aspirin or NSAIDs. Med Lett Drugs Ther 2010; 52(1333): 17-19.

3. Pilgrim S, Velchuru V, Waters G. Colorectal dis. diaphragm disease and small bowel enteropathy due to non-steroidal anti-inflammatory drugs; a surgical perspective. Colorectal Dis 2009; 21.

4. Kelly ME, McMahon LE, Jaroszewski DE, Yousfi MM, De Petris G, Swain JM. Small-bowel diaphragm disease: seven surgical cases. Arch Surg 2005; 140(12): 1162-1166.

5. Shiotani A, Kamada T, Haruma K. Low-dose aspirin-induced gastrointestinal diseases: past, present, and future. J Gastroenterol 2008; 43(8): 581-588.

6. Adebayo D, Bjarnason I. Is non-steroidal anti-inflammatory drug (NSAID) enteropathy clinically more important than NSAID gastropathy? Postgrad Med J 2006; 82(965): 186-191.

7. Lanas A, Sopeña F. Nonsteroidal anti-inflammatory drugs and lower gastrointestinal complications. Gastroenterol Clin North Am 2009; 38(2): 333-352.

8. Bjarnason I, Takeuchi K. Intestinal permeability in the pathogenesis of NSAID-induced enteropathy. J Gastroenterol 2009; 44Suppl 19: 23-29.

9. Higuchi K, Umegaki E, Watanabe T, Yoda Y, Morita E, Murano M, Tokioka S, Arakawa T. Present status and strategy of NSAI Ds-induced small bowel injury. J Gastroenterol 2009; 44(9): 879-888.

10. Fortun PJ, Hawkey CJ. Nonsteroidal antiinflammatory drugs and the small intestine. Curr Opin Gastroenterol 2007; 23(2): 134-141.

11. Postgrad Med J. 2006; 82(965): 186-91. NSAIDs, coxibs, and the intestine. J Cardiovasc Pharmacol 2006; 47 Suppl 1: S72-75.

12. Maiden L. Capsule endoscopic diagnosis of nonsteroidal antiinflammatory drug-induced enteropathy. J Gastroenterol 2009; 44 Suppl 19: 64-71.

13. Romero J, Herrerías JM. Capsule endoscopy and nonsteroidal antiinflammatory drugs (NSAID)-induced enteropathy - a bit of light in a long, dark tunnel. Rev Esp Enferm Dig 2010; 102(2): 73-79.

14. Gay G, Delvaux M, Frederic M. Capsule endoscopy in non-steroidal anti-inflammatory drugs-enteropathy and miscellaneous, rare intestinal diseases. World J Gastroenterol 2008; 14(34): 5237-5244.

15. Tachecí I, Kopácová M, Rejchrt S, Bures J. Non-steroidal anti-inflammatory drug induced injury to the small intestine. n2010; 53(1): 3-11.

16. Laine L, Smith R, Min K, Chen C, Dubois RW. Systematic review: the lower gastrointestinal adverse effects of non-steroidal antiinflammatory drugs. Aliment Pharmacol Ther 2006; 24(5): 751-767.